Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz

Lundbeck makes bid for Avadel, trying to displace Alkermes

DRRA2 hours ago 0

PharmaShots Weekly Snapshots (Nov 10, 2025 – Nov 14, 2025)     

DRRA2 hours ago 0

Merck stakes $9.2B on Cidara and its long-acting flu drug

DRRA2 hours ago 0

Adagene Enters ~$845M Licensing Deal with Third Arc Bio to Develop Masked CD3 T Cell Engagers

DRRA3 hours ago 0